Boston Scientific Acquires Devoro Medical

September 21, 2021

Boston Scientific agreed to acquire the remaining 84% of Devoro Medical, developer of the WOLF Thrombectomy Platform, paying approximately $269 million upfront plus up to $67 million in milestone payments. Boston Scientific had been a strategic investor in Devoro since 2019 (holding ~16%); the acquisition expands Boston Scientific’s clot-management and peripheral interventions product portfolio by adding a non-console, lytic-free thrombectomy technology.

Buyers
Boston Scientific Corporation
Targets
Devoro Medical, Inc.
Industry
Medical Devices
Location
United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.